← All trials
NCT00219466
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2005
- Primary completion
- Oct 31, 2005
- Completion date
- Oct 31, 2005
- First posted
- Sep 22, 2005
- Last posted
- Aug 22, 2011
- Enrollment
- 112
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Johnson and JohnsonLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.